Amlodipine/Folic Acid

氨氯地平/叶酸

Report date: 2024/08/06 17:34:36

Base Information

Drug NameAmlodipine/Folic Acid
Drug Alias Name氨氯地平+叶酸Folic acid+amlodipine叶酸+氨氯地平Folic acid/amlodipineAmlodipine-FA +[9] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaEssential Hypertension
Original Approved Country/TerritoryMainland China
Original Approved Date2018/12/17
Country/TerritoryMainland China
CombinationsYes Amlodipine BesylateFolic Acid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Ausa Pharmed Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Ausa Pharmaceutical Co Ltd
Inactive CompaniesAnhui Huaanfo Pharmaceutical Co LtdAnhui Biomedical Research Institute
Active IndicationsEssential Hypertension
Inactive IndicationsHypertension

Other Information

ATC CodeB03BB51
Related LinksN/A